feed,title,long_url,short_url
Benzinga,ImmunoGen's Flagship Cancer Therapy Draws AbbVie's Attention With $10.1B Deal,https://benzinga.com/general/biotech/23/11/36020779/immunogens-flagship-cancer-therapy-draws-abbvies-attention-with-10-1b-deal,https://da.gd/pxvJ
